Colorectal cancer
653 results
1 - 100
Colorectal cancer 
Antioxidants don't prevent colorectal cancer- Screening and prevention of colorectal cancer
- Adjuvant chemotherapy in colorectal cancer
Long‐term results of laparoscopic colorectal cancer resection- Symptoms not reliable in diagnosing colorectal cancer
- Palliative chemotherapy for advanced or metastatic colorectal cancer
- Aspirin = screening to prevent colorectal cancer mortality
- Anti‐angiogenic therapies for metastatic colorectal cancer
- Perioperative blood transfusions and recurrence of colorectal cancer
- Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
- Screening for colorectal cancer using the faecal occult blood test, Hemoccult
- USPSTF 2016: updated recommendations for colorectal cancer screening
- Chemotherapy for advanced or metastatic colorectal cancer
- Fecal immunochemical testing accurate for colorectal cancer screening
- Blood CEA levels for detecting recurrent colorectal cancer
- Colorectal cancer risk is increased in first-degree relatives
- Herbal medicines for advanced colorectal cancer: Cochrane systematic review
- Chemotherapy for advanced or metastatic colorectal cancer (2)
- American Gastroenterological Association position statements for colorectal cancer screening
- Anti-angiogenic therapies for metastatic colorectal cancer
- Nonadvanced colon adenoma may not increase colorectal cancer risk
- Flex sig reduces incidence and mortality of colorectal cancer
- SR: BRCA mutations are not associated with colorectal cancer
- Colorectal cancer screening modalities: variable uptake, variable yield (SAVE)
- Workload and surgeon´s specialty for outcome after colorectal cancer surgery
- Long-term results of laparoscopic colorectal cancer resection
- Selective internal radiation therapy for liver metastases from colorectal cancer
- Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer
- Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals
- Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases
- USPSTF: Some adults should take aspirin to prevent CVD, colorectal cancer
- Erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery
- Follow‐up strategies for patients treated for non‐metastatic colorectal cancer
- Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer
- Follow-up strategies for patients treated for non-metastatic colorectal cancer
- Selective internal radiation therapy for liver metastases from colorectal cancer
- Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer
- Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer
- Chinese medical herbs for chemotherapy side effects in colorectal cancer patients
- No increased survival benefit to intensive follow-up after colorectal cancer surgery
- Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases
- Second-line chemotherapy in advanced and metastatic colorectal cancer
- Accuracy of fecal DNA and fecal immunochemical test for colorectal cancer detection
- Duration of adjuvant chemotherapy for patients with non‐metastatic colorectal cancer
- Pre and peri‐operative erythropoeitin for reducing allogeneic blood transfusions in colorectal cancer surgery.
- High adenoma detection rate during colonoscopy associated with lower incidence of colorectal cancer
- Long-term follow-up of CAPP2: aspirin prevents colorectal cancer in Lynch syndrome carriers
- FIT more acceptable with better detection rate than gFOBT for colorectal cancer screening
- Invitation to a single colonoscopy has only modest impact on colorectal cancer incidence (NordICC)
- Exercise plus behavioral support significantly increases overall survival in patients with colorectal cancer (CHALLENGE)
- Mailing FIT or gFOBT directly to patients increases uptake of colorectal cancer screening
- Oral versus intravenous fluoropyrimidines for colorectal cancer
- Network meta-analysis: Limited data show that high-dose aspirin decreases incidence of colorectal cancer
- Additional evidence of no increased survival benefit to intensive follow-up after colorectal cancer surgery
- Low-dose aspirin reduces colorectal cancer recurrence in persons with PI3K mutation (NNT = 16 over 3 years)
- Coriolus (Trametes) versicolor mushroom to reduce adverse effects from chemotherapy or radiotherapy in people with colorectal cancer
- FIT has similar yield as colonoscopy for colorectal cancer and advanced adenoma over 10 years
- Every-other-year FIT is at least as effective as a single sigmoidoscopy to detect colorectal cancer
- Mailed FIT kit results in highest colorectal cancer screening rate for adults aged 45 to 49 years
- Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver
- Second-line systemic therapy for metastatic colorectal cancer: Cochrane systematic review
- Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer
- Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals
- Results of fecal immunochemical tests for colorectal cancer screening not affected by NSAIDs, aspirin, or anticoagulants
- Consider not screening average-risk adults aged 45-49 years for colorectal cancer; stick to usual means of screening
- Cell-free DNA blood test 83% sensitive for colorectal cancer, 13% sensitive for advanced adenoma; mortality data lacking (ECLIPSE)
- DNA-based blood test: 82% sensitive and 91% specific for colorectal cancer, but only 12% sensitive for advanced adenoma
- Colonoscopy more than 10 months after positive FIT increases risk of colorectal cancer and more advanced-stage disease
- Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable Stage IV colorectal cancer: Cochrane systematic review
- Physical activity interventions for disease‐related physical and mental health during and following treatment in people with non‐advanced colorectal cancer
- Radiofrequency ablation in the treatment of liver metastases from colorectal cancer: Cochrane systematic review
- Prehabilitation versus no prehabilitation to improve functional capacity, reduce postoperative complications and improve quality of life in colorectal cancer surgery
- Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer: Cochrane systematic review
- Physical activity interventions for disease-related physical and mental health during and following treatment in people with non-advanced colorectal cancer
- Contrast‐enhanced ultrasound compared with computed tomography, magnetic resonance imaging, and positron emission tomography‐computed tomography for diagnosing liver metastases in people with newly diagnosed colorectal cancer
- Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression‐free survival in patients with advanced and/or metastatic colorectal cancer
- Guaiac‐based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average‐risk individuals